RIVAS MARIO (Chief Executive Officer) received a stock award from TRANSPHORM, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/4/2023ACC: 0001209191-23-000855
DirectorOfficer· Chief Executive Officer
Since Feb 2020
+4.01K
Net shares
Net buyer
$68.2K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
16.54K acquired · 12.53K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+16.54K
Price / share
—
Trade value
—
% of position
14.0%
1/1/2023
118.20K→134.75K
Common Stock
Direct
Shares
−12.53K
Price / share
$5.44
Trade value
$68.18K
% of position
9.3%
1/1/2023
134.75K→122.21K
Total
Net shares
+4.01K
Net value
-$68.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2023 | A · Award | +16.54K | — | — | 14.0% | 118.20K | 134.75K |
| Common Stock Direct | 1/1/2023 | F · Tax Withholding | −12.53K | $5.44 | $68.18K | 9.3% | 134.75K | 122.21K |
| Total | +4.01K | -$68.18K | ||||||
Derivative Transactions0
No derivative transactions reported